NovoCure Ownership 2024 | Who Owns NovoCure Now?

Overview Forecast RevenueFinancials Chart Transcripts

Institutional Ownership

86.62%

Insider Ownership

9.22%

Retail Ownership

4.16%

Institutional Holders

244.00

NovoCure Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
FMR LLC	15.05%	0.02%	16,141,586	77,618	0.48%	276,505,363	Jun 30, 2024
BLACKROCK INC.	11.31%	0.00%	12,132,397	3,047,985	33.55%	207,827,962	Jun 30, 2024
CAPITAL INTERNATIONAL INVESTORS	10.90%	0.04%	11,696,348	2,832,256	31.95%	200,358,441	Jun 30, 2024
VANGUARD GROUP INC	10.37%	0.00%	11,127,365	1,103,384	11.01%	190,611,762	Jun 30, 2024
STATE STREET CORP	2.80%	0.00%	3,005,689	-357,176	-10.62%	51,487,453,000	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	2.21%	0.00%	2,375,386	732,254	44.56%	40,698,299	Jun 30, 2024
CAPITAL WORLD INVESTORS	2.15%	0.01%	2,308,215	-	-	39,539,723	Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/	2.01%	0.00%	2,156,021	-222,919	-9.37%	36,933,000	Jun 30, 2024
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.	1.60%	0.02%	1,712,393	1,712,393	100.00%	29,334,000	Jun 30, 2024
BAILLIE GIFFORD & CO	1.57%	0.02%	1,687,521	-302,854	-15.22%	28,907,235	Jun 30, 2024
NORDWAND ADVISORS, LLC	1.41%	11.32%	1,515,000	-	-	25,951,950	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	1.16%	0.05%	1,244,164	-144,894	-10.43%	21,312,529	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	1.12%	0.01%	1,205,892	-17,470	-1.43%	20,656,930	Jun 30, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC	1.03%	0.07%	1,104,660	46,437	4.39%	18,922,826	Jun 30, 2024
FRONTIER CAPITAL MANAGEMENT CO LLC	0.96%	0.17%	1,028,331	107,215	11.64%	17,615,312	Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC	0.77%	0.00%	823,393	688,510	510.45%	14,104,722	Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.75%	0.00%	808,104	277,049	52.17%	13,842,822	Jun 30, 2024
MORGAN STANLEY	0.75%	0.00%	806,524	-950,115	-54.09%	13,815,758	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.71%	0.02%	760,175	480,600	171.90%	13,021,798	Jun 30, 2024
FEDERATED HERMES, INC.	0.69%	0.03%	742,927	40,870	5.82%	12,726,340,000	Jun 30, 2024

NovoCure's largest institutional shareholder is FMR LLC, holding 15.05% of the company's total share outstanding, currently valued at $276.51M. The top 10 institutional shareholders own together 59.98% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
NORDWAND ADVISORS, LLC	1.41%	11.32%	1,515,000	-	-	25,951,950	Jun 30, 2024
INVUS FINANCIAL ADVISORS, LLC	0.33%	6.74%	350,884	-	-	6,010,643	Jun 30, 2024
SUPERSTRING CAPITAL MANAGEMENT LP	0.06%	1.44%	66,892	66,892	100.00%	1,145,860	Jun 30, 2024
PALO ALTO INVESTORS LP	0.52%	1.12%	561,908	-	-	9,625,484	Jun 30, 2024
TAYLOR FRIGON CAPITAL MANAGEMENT LLC	0.12%	1.09%	133,298	6,384	5.03%	2,283,395	Jun 30, 2024
ESSEX INVESTMENT MANAGEMENT CO LLC	0.15%	0.52%	161,486	161,486	100.00%	2,766,255	Jun 30, 2024
BIRCHVIEW CAPITAL, LP	0.02%	0.32%	20,000	20,000	100.00%	342,600	Jun 30, 2024
PDT PARTNERS, LLC	0.18%	0.31%	188,422	100	0.05%	3,227,669	Jun 30, 2024
FRONTIER CAPITAL MANAGEMENT CO LLC	0.96%	0.17%	1,028,331	107,215	11.64%	17,615,312	Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.	0.10%	0.16%	108,900	-586,859	-84.35%	1,865,457	Jun 30, 2024
OLYMPIAD RESEARCH LP	0.01%	0.16%	12,876	12,876	100.00%	220,566	Jun 30, 2024
ALPHA DNA INVESTMENT MANAGEMENT LLC	0.02%	0.14%	20,353	20,353	100.00%	348,647	Jun 30, 2024
SCIENTECH RESEARCH LLC	0.04%	0.13%	37,647	37,647	100.00%	644,893	Jun 30, 2024
LEGATO CAPITAL MANAGEMENT LLC	0.05%	0.13%	55,567	55,567	100.00%	951,863	Jun 30, 2024
AIGEN INVESTMENT MANAGEMENT, LP	0.03%	0.12%	35,189	24,312	223.52%	602,788	Jun 30, 2024
BRIDGEFRONT CAPITAL, LLC	0.01%	0.12%	16,102	16,102	100.00%	275,827	Jun 30, 2024
ENGINEERS GATE MANAGER LP	0.27%	0.11%	292,863	10,026	3.54%	5,016,743	Jun 30, 2024
SEVEN EIGHT CAPITAL, LP	0.06%	0.11%	61,909	61,909	100.00%	1,060,501	Jun 30, 2024
QUANTINNO CAPITAL MANAGEMENT LP	0.33%	0.11%	354,456	297,183	518.89%	6,071,831	Jun 30, 2024
CORTON CAPITAL INC.	0.01%	0.11%	11,697	-24,762	-67.92%	200,370	Jun 30, 2024

The largest NovoCure shareholder by % of total assets is NORDWAND ADVISORS, LLC. The company owns 1.51M shares of NovoCure (NVCR), representing 11.32% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BLACKROCK INC.	11.31%	0.00%	12,132,397	3,047,985	33.55%	207,827,962	Jun 30, 2024
CAPITAL INTERNATIONAL INVESTORS	10.90%	0.04%	11,696,348	2,832,256	31.95%	200,358,441	Jun 30, 2024
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.	1.60%	0.02%	1,712,393	1,712,393	100.00%	29,334,000	Jun 30, 2024
VANGUARD GROUP INC	10.37%	0.00%	11,127,365	1,103,384	11.01%	190,611,762	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	2.21%	0.00%	2,375,386	732,254	44.56%	40,698,299	Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC	0.77%	0.00%	823,393	688,510	510.45%	14,104,722	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.71%	0.02%	760,175	480,600	171.90%	13,021,798	Jun 30, 2024
SILVERCREST ASSET MANAGEMENT GROUP LLC	0.36%	0.05%	385,410	385,410	100.00%	6,602,073	Jun 30, 2024
PANAGORA ASSET MANAGEMENT INC	0.38%	0.04%	409,794	309,805	309.84%	7,019,771	Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC	0.40%	0.01%	431,445	302,351	234.21%	7,390,652	Jun 30, 2024
QUANTINNO CAPITAL MANAGEMENT LP	0.33%	0.11%	354,456	297,183	518.89%	6,071,831	Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.75%	0.00%	808,104	277,049	52.17%	13,842,822	Jun 30, 2024
UBS GROUP AG	0.25%	0.00%	267,627	267,627	100.00%	4,584,451	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.21%	0.00%	225,506	197,614	708.50%	3,862,918	Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC	0.22%	0.00%	232,824	195,645	526.22%	3,988,275	Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.	0.55%	0.02%	594,998	167,719	39.25%	10,192,316	Jun 30, 2024
ESSEX INVESTMENT MANAGEMENT CO LLC	0.15%	0.52%	161,486	161,486	100.00%	2,766,255	Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC	0.41%	0.00%	443,699	154,590	53.47%	7,600,564	Jun 30, 2024
BANK OF NEW YORK MELLON CORP	0.39%	0.00%	419,960	152,185	56.83%	7,193,923	Jun 30, 2024
FRONTIER CAPITAL MANAGEMENT CO LLC	0.96%	0.17%	1,028,331	107,215	11.64%	17,615,312	Jun 30, 2024

As of Jun 30 2024, NovoCure's largest institutional buyer is BLACKROCK INC.. The company purchased 3.05M stocks of NVCR, valued at $207.83M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MORGAN STANLEY	0.75%	0.00%	806,524	-950,115	-54.09%	13,815,758	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.51%	0.00%	551,636	-703,495	-56.05%	9,449,524	Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.	0.10%	0.16%	108,900	-586,859	-84.35%	1,865,457	Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC	0.33%	0.04%	354,033	-559,768	-61.26%	6,064,584	Jun 30, 2024
RHENMAN & PARTNERS ASSET MANAGEMENT AB	-	-	-	-495,307	-100.00%	-	Jun 30, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC	-	-	-	-475,226	-100.00%	-	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.30%	0.01%	322,507	-467,853	-59.19%	5,524,545	Jun 30, 2024
STATE STREET CORP	2.80%	0.00%	3,005,689	-357,176	-10.62%	51,487,453,000	Jun 30, 2024
SQUAREPOINT OPS LLC	-	-	-	-331,184	-100.00%	-	Jun 30, 2024
BAILLIE GIFFORD & CO	1.57%	0.02%	1,687,521	-302,854	-15.22%	28,907,235	Jun 30, 2024
BARCLAYS PLC	-	-	-	-300,000	-100.00%	-	Jun 30, 2024
MARSHALL WACE, LLP	0.46%	0.01%	497,474	-272,053	-35.35%	8,521,730	Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC	0.09%	0.01%	101,140	-262,637	-72.20%	1,732,527	Jun 30, 2024
D. E. SHAW & CO., INC.	0.65%	0.01%	699,294	-254,618	-26.69%	11,978,906	Jun 30, 2024
MAN GROUP PLC	0.28%	0.01%	300,171	-243,653	-44.80%	5,141,929	Jun 30, 2024
NATIONAL BANK OF CANADA /FI/	-	-	-	-233,000	-100.00%	-	Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/	2.01%	0.00%	2,156,021	-222,919	-9.37%	36,933,000	Jun 30, 2024
INVENOMIC CAPITAL MANAGEMENT LP	-	-	-	-218,990	-100.00%	-	Jun 30, 2024
SG AMERICAS SECURITIES, LLC	0.13%	0.01%	141,609	-217,909	-60.61%	2,426,000	Jun 30, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP	0.07%	0.01%	76,305	-156,406	-67.21%	1,307,000	Jun 30, 2024

As of Jun 30 2024, NovoCure's biggest institutional seller is MORGAN STANLEY. The company sold -0.95M shares of NVCR, valued at $13.82M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.	1.60%	0.02%	1,712,393	1,712,393	100.00%	29,334,000	Jun 30, 2024
SILVERCREST ASSET MANAGEMENT GROUP LLC	0.36%	0.05%	385,410	385,410	100.00%	6,602,073	Jun 30, 2024
ESSEX INVESTMENT MANAGEMENT CO LLC	0.15%	0.52%	161,486	161,486	100.00%	2,766,255	Jun 30, 2024
STATE OF NEW JERSEY COMMON PENSION FUND D	0.08%	0.01%	84,500	84,500	100.00%	1,447,485	Jun 30, 2024
SUPERSTRING CAPITAL MANAGEMENT LP	0.06%	1.44%	66,892	66,892	100.00%	1,145,860	Jun 30, 2024
COREBRIDGE FINANCIAL, INC.	0.05%	0.01%	57,294	57,294	100.00%	982,019	Jun 30, 2024
LEGATO CAPITAL MANAGEMENT LLC	0.05%	0.13%	55,567	55,567	100.00%	951,863	Jun 30, 2024
STRS OHIO	0.04%	0.00%	44,500	44,500	100.00%	762,285,000	Jun 30, 2024
SCIENTECH RESEARCH LLC	0.04%	0.13%	37,647	37,647	100.00%	644,893	Jun 30, 2024
THRIVENT FINANCIAL FOR LUTHERANS	0.03%	0.00%	36,495	36,495	100.00%	626,000	Jun 30, 2024
NEBULA RESEARCH & DEVELOPMENT LLC	0.02%	0.06%	21,042	21,042	100.00%	360,449	Jun 30, 2024
ALPHA DNA INVESTMENT MANAGEMENT LLC	0.02%	0.14%	20,353	20,353	100.00%	348,647	Jun 30, 2024
BIRCHVIEW CAPITAL, LP	0.02%	0.32%	20,000	20,000	100.00%	342,600	Jun 30, 2024
BRIDGEFRONT CAPITAL, LLC	0.01%	0.12%	16,102	16,102	100.00%	275,827	Jun 30, 2024
CAMPBELL & CO INVESTMENT ADVISER LLC	0.01%	0.02%	15,776	15,776	100.00%	270,243	Jun 30, 2024
BERKSHIRE ASSET MANAGEMENT LLC/PA	0.01%	0.01%	15,000	15,000	100.00%	256,950	Jun 30, 2024
OLYMPIAD RESEARCH LP	0.01%	0.16%	12,876	12,876	100.00%	220,566	Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.	0.01%	0.00%	12,110	12,110	100.00%	207,444	Jun 30, 2024
CHOREO, LLC	0.01%	0.00%	11,131	11,131	100.00%	191,904	Jun 30, 2024
COMMONWEALTH EQUITY SERVICES, LLC	0.01%	0.00%	10,463	10,463	100.00%	179,000	Jun 30, 2024
AMERITAS INVESTMENT PARTNERS, INC.	0.01%	0.01%	10,433	10,433	100.00%	178,717	Jun 30, 2024
CERITY PARTNERS LLC	0.01%	0.00%	10,377	10,377	100.00%	177,756	Jun 30, 2024
STATE OF WYOMING	0.01%	0.02%	5,974	5,974	100.00%	102,335	Jun 30, 2024
PEAK6 INVESTMENTS LLC	0.00%	0.00%	5,000	5,000	100.00%	85,650	Jun 30, 2024
MEEDER ASSET MANAGEMENT INC	0.00%	0.01%	4,721	4,721	100.00%	80,871	Jun 30, 2024
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.	0.00%	0.00%	3,213	3,213	100.00%	56,645	Jun 30, 2024
NISA INVESTMENT ADVISORS, LLC	0.00%	0.00%	2,777	2,777	100.00%	47,570	Jun 30, 2024
RIDGEWOOD INVESTMENTS LLC	0.00%	0.01%	1,637	1,637	100.00%	28,042	Jun 30, 2024
TUCKER ASSET MANAGEMENT LLC	0.00%	0.01%	1,600	1,600	100.00%	27,408	Jun 30, 2024
COPPELL ADVISORY SOLUTIONS LLC	0.00%	0.00%	910	910	100.00%	15,588	Jun 30, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC	0.00%	0.01%	600	600	100.00%	10,278	Jun 30, 2024
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC	0.00%	-	593	593	100.00%	10,158	Jun 30, 2024
THURSTON, SPRINGER, MILLER, HERD & TITAK, INC.	0.00%	0.00%	509	509	100.00%	8,715	Jun 30, 2024
SRS CAPITAL ADVISORS, INC.	0.00%	0.00%	484	484	100.00%	8,291	Jun 30, 2024
MACROVIEW INVESTMENT MANAGEMENT LLC	0.00%	0.01%	399	399	100.00%	6,835	Jun 30, 2024
ASHTON THOMAS PRIVATE WEALTH, LLC	0.00%	0.00%	173	173	100.00%	2,963	Jun 30, 2024
PRIVATE WEALTH MANAGEMENT GROUP, LLC	0.00%	0.00%	80	80	100.00%	1,371	Jun 30, 2024
TFC FINANCIAL MANAGEMENT, INC.	-	0.00%	19	19	100.00%	326	Jun 30, 2024
MATHER GROUP, LLC.	-	-	15	15	100.00%	234	Jun 30, 2024
MV CAPITAL MANAGEMENT, INC.	-	-	14	14	100.00%	240	Jun 30, 2024
ROTHSCHILD INVESTMENT LLC	-	-	10	10	100.00%	171	Jun 30, 2024
PFG PRIVATE WEALTH MANAGEMENT, LLC	-	0.00%	6	6	100.00%	103	Jun 30, 2024
PLANNING CAPITAL MANAGEMENT CORP	-	0.00%	5	5	100.00%	86	Jun 30, 2024

NovoCure's largest new institutional shareholder by number of shares is T. ROWE PRICE INVESTMENT MANAGEMENT, INC., purchased 1.71M shares, valued at $29.33M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RHENMAN & PARTNERS ASSET MANAGEMENT AB	-	-	-	-495,307	-100.00%	-	Jun 30, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC	-	-	-	-475,226	-100.00%	-	Jun 30, 2024
SQUAREPOINT OPS LLC	-	-	-	-331,184	-100.00%	-	Jun 30, 2024
BARCLAYS PLC	-	-	-	-300,000	-100.00%	-	Jun 30, 2024
NATIONAL BANK OF CANADA /FI/	-	-	-	-233,000	-100.00%	-	Jun 30, 2024
INVENOMIC CAPITAL MANAGEMENT LP	-	-	-	-218,990	-100.00%	-	Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD	-	-	-	-123,939	-100.00%	-	Jun 30, 2024
HAP TRADING, LLC	-	-	-	-120,100	-100.00%	-	Jun 30, 2024
ALLIANZ ASSET MANAGEMENT GMBH	-	-	-	-110,500	-100.00%	-	Jun 30, 2024
MITSUBISHI UFJ TRUST & BANKING CORP	-	-	-	-110,261	-100.00%	-	Jun 30, 2024
UBS OCONNOR LLC	-	-	-	-100,000	-100.00%	-	Jun 30, 2024
HRT FINANCIAL LP	-	-	-	-88,730	-100.00%	-	Jun 30, 2024
CIBC WORLD MARKETS CORP	-	-	-	-59,432	-100.00%	-	Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC	-	-	-	-50,000	-100.00%	-	Jun 30, 2024
TREASURER OF THE STATE OF NORTH CAROLINA	-	-	-	-46,854	-100.00%	-	Jun 30, 2024
POINT72 (DIFC) LTD	-	-	-	-37,036	-100.00%	-	Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.	-	-	-	-32,600	-100.00%	-	Jun 30, 2024
SIMPLEX TRADING, LLC	-	-	-	-28,986	-100.00%	-	Jun 30, 2024
CAPSTONE INVESTMENT ADVISORS, LLC	-	-	-	-25,835	-100.00%	-	Jun 30, 2024
JEFFERIES FINANCIAL GROUP INC.	-	-	-	-25,310	-100.00%	-	Jun 30, 2024
CAPITAL FUND MANAGEMENT S.A.	-	-	-	-23,500	-100.00%	-	Jun 30, 2024
GRAHAM CAPITAL MANAGEMENT, L.P.	-	-	-	-18,716	-100.00%	-	Jun 30, 2024
BESSEMER GROUP INC	-	-	-	-17,390	-100.00%	-	Jun 30, 2024
FOX RUN MANAGEMENT, L.L.C.	-	-	-	-15,809	-100.00%	-	Jun 30, 2024
LMR PARTNERS LLP	-	-	-	-15,374	-100.00%	-	Jun 30, 2024
MARATHON TRADING INVESTMENT MANAGEMENT LLC	-	-	-	-15,000	-100.00%	-	Jun 30, 2024
XPONANCE, INC.	-	-	-	-13,623	-100.00%	-	Jun 30, 2024
CENTIVA CAPITAL, LP	-	-	-	-13,141	-100.00%	-	Jun 30, 2024
LINDEN THOMAS ADVISORY SERVICES, LLC	-	-	-	-13,126	-100.00%	-	Jun 30, 2024
VERSOR INVESTMENTS LP	-	-	-	-12,500	-100.00%	-	Jun 30, 2024
WOLVERINE TRADING, LLC	-	-	-	-11,668	-100.00%	-	Jun 30, 2024
PATHSTONE HOLDINGS, LLC	-	-	-	-10,559	-100.00%	-	Jun 30, 2024
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.	-	-	-	-10,332	-100.00%	-	Jun 30, 2024
HEADLANDS TECHNOLOGIES LLC	-	-	-	-8,589	-100.00%	-	Jun 30, 2024
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	-	-	-	-7,257	-100.00%	-	Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-3,143	-100.00%	-	Jun 30, 2024
CAPTION MANAGEMENT, LLC	-	-	-	-2,493	-100.00%	-	Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.	-	-	-	-1,750	-100.00%	-	Jun 30, 2024
FIDELIS CAPITAL PARTNERS, LLC	-	-	-	-1,008	-100.00%	-	Jun 30, 2024
LEGACY BRIDGE, LLC	-	-	-	-400	-100.00%	-	Jun 30, 2024
CAPITAL ADVISORS, LTD. LLC	-	-	-	-388	-100.00%	-	Jun 30, 2024
CLEAR STREET MARKETS LLC	-	-	-	-251	-100.00%	-	Jun 30, 2024
SANDY SPRING BANK	-	-	-	-185	-100.00%	-	Jun 30, 2024
SACHETTA, LLC	-	-	-	-78	-100.00%	-	Jun 30, 2024
NBC SECURITIES, INC.	-	-	-	-37	-100.00%	-	Jun 30, 2024
BELL INVESTMENT ADVISORS, INC	-	-	-	-36	-100.00%	-	Jun 30, 2024
CENTRAL TRUST CO	-	-	-	-18	-100.00%	-	Jun 30, 2024

NovoCure's largest sold out institutional shareholder by shares sold is RHENMAN & PARTNERS ASSET MANAGEMENT AB, sold -0.50M shares, valued at -, as of undefined.

NovoCure Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
SPARROW FUNDS	1.63%	5,800	-	-	Feb 29, 2024
Virtus Artificial Intelligence & Technology Opportunities Fund	1.27%	5,000,000	-	-	Jan 31, 2024
Virtus Artificial Intelligence & Technology Opportunities Fund	1.27%	5,000,000	-	-	Jan 31, 2024
Virtus Dividend, Interest & Premium Strategy Fund	0.93%	2,220,000	-	-	Jan 31, 2024
Virtus Equity & Convertible Income Fund	0.91%	1,810,000	-	-	Jan 31, 2024
Virtus Diversified Income & Convertible Fund	0.77%	1,575,000	-	-	Jan 31, 2024
Virtus Dividend, Interest & Premium Strategy Fund	0.67%	1,580,000	-	-	Jan 31, 2024
Virtus Strategy Trust	0.66%	14,050,000	-	-	Mar 28, 2024
Virtus Equity & Convertible Income Fund	0.65%	1,295,000	-	-	Jan 31, 2024
Virtus Convertible & Income Fund II	0.64%	2,405,000	-	-	Jan 31, 2024
Virtus Convertible & Income Fund	0.63%	3,120,000	-	-	Jan 31, 2024
Virtus Strategy Trust	0.58%	12,240,000	-	-	Mar 28, 2024
Fiera Capital Series Trust	0.42%	8,400	-	-	Jun 30, 2023
Virtus Diversified Income & Convertible Fund	0.42%	850,000	-	-	Jan 31, 2024
DSS AMERICAFIRST QUANTITATIVE FUNDS	0.41%	2,699	-	-	Mar 31, 2021
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC	0.28%	225,000	-	-	Dec 29, 2023
Virtus Investment Trust	0.28%	9,525,000	-	-	Mar 28, 2024
HSBC FUNDS	0.26%	8,430	-	-	Jan 31, 2024
Virtus Investment Trust	0.25%	8,475,000	-	-	Mar 28, 2024
ELLSWORTH GROWTH & INCOME FUND LTD	0.24%	340,000	-	-	Dec 29, 2023
BANCROFT FUND LTD	0.22%	310,000	-	-	Dec 29, 2023
TETON WESTWOOD FUNDS	0.19%	125,000	-	-	Dec 29, 2023
VANGUARD VALLEY FORGE FUNDS	0.14%	73,502	-	-	Mar 31, 2024
REYNOLDS FUNDS INC	0.12%	1,300	-	-	Mar 31, 2024
ADVISORS' INNER CIRCLE FUND	0.05%	1,298,512	-	-	Jan 31, 2024
NORTHERN LIGHTS FUND TRUST II	0.05%	571,901	635,656	-997.03%	Jan 31, 2024
BLACKROCK LARGE CAP SERIES FUNDS, INC.	0.03%	1,549,000	-	-	Feb 29, 2024
BLACKROCK LARGE CAP SERIES FUNDS, INC.	0.03%	1,549,000	-	-	Feb 29, 2024
Cushing Mutual Funds Trust	0.03%	918	-	-	Aug 31, 2023
BUFFALO FUNDS	0.03%	172,925	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.02%	8,927,607	-1,392,938	-13.50%	Mar 31, 2024
Northern Lights Variable Trust	0.02%	18,975	-	-	Mar 31, 2024
SARATOGA ADVANTAGE TRUST	0.01%	854	-	-	Feb 29, 2024
TrimTabs ETF Trust	0.01%	8,820	-	-	Jan 31, 2024
TIAA SEPARATE ACCOUNT VA 1	0.01%	2,637	-	-	Mar 31, 2024
EXCHANGE TRADED CONCEPTS TRUST	0.01%	69,199	18,553	36.63%	Jan 31, 2024
Nushares ETF Trust	0.01%	74,340	47,123	173.14%	Jan 31, 2024
VANGUARD HORIZON FUNDS	0.01%	239,370	-	-	Mar 31, 2024
Engine No. 1 ETF Trust	0.01%	505	-	-	Jan 31, 2024
AIM SECTOR FUNDS (INVESCO SECTOR FUNDS)	0.01%	165,069	-	-	Jan 31, 2024
ETF Managers Trust	0.01%	45,643	-	-	Dec 31, 2023
John Hancock Exchange-Traded Fund Trust	0.00%	30,447	-	-	Jan 31, 2024
FIRST TRUST EXCHANGE-TRADED FUND IV	0.00%	1,090,000	-	-	Jan 31, 2024
VANGUARD EXPLORER FUND	0.00%	56,067	-	-	Jan 31, 2024
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.	0.00%	9,506	-	-	Mar 31, 2024
NORTHERN LIGHTS FUND TRUST III	0.00%	47,646	19,489	69.22%	Mar 31, 2024
Nuveen NASDAQ 100 Dynamic Overwrite Fund	0.00%	313	-	-	Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	64,633	-5,172	-7.41%	Mar 31, 2024
VICTORY PORTFOLIOS	0.00%	59,280	-	-	Mar 31, 2024
Forward Funds	0.00%	3,900	-	-	Sep 30, 2022
Columbia Funds Variable Series Trust II	0.00%	58,674	-	-	Mar 31, 2024
T. Rowe Price Exchange-Traded Funds, Inc.	0.00%	12,177	12,177	-	Mar 31, 2024
MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC	0.00%	809	-	-	Sep 30, 2020
VANGUARD WORLD FUND	0.00%	353,760	-8,976	-2.47%	Feb 29, 2024
PFS FUNDS	0.00%	18,946	-	-	Feb 29, 2024
Mutual of America Variable Insurance Portfolios, Inc.	0.00%	988	-	-	Sep 30, 2023
VANGUARD QUANTITATIVE FUNDS	0.00%	6,600	-	-	Mar 31, 2024
VANGUARD TAX-MANAGED FUNDS	0.00%	252,705	206,559	447.62%	Mar 31, 2024
MUTUAL OF AMERICA INVESTMENT CORP	0.00%	45,473	-	-	Mar 31, 2024
TIMOTHY PLAN	0.00%	4,700	-	-	Mar 31, 2024
AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST)	0.00%	212,891	-	-	Feb 29, 2024
VANGUARD WHITEHALL FUNDS	0.00%	78,897	-	-	Jan 31, 2024
HC CAPITAL TRUST	0.00%	27,674	-	-	Mar 31, 2024
MML SERIES INVESTMENT FUND	0.00%	7,500	-	-	Dec 31, 2023
TIAA-CREF LIFE FUNDS	0.00%	1,767	-	-	Mar 31, 2024
SEI Catholic Values Trust	0.00%	1,591	-	-	Feb 29, 2024
Victory Portfolios II	0.00%	29,368	-	-	Mar 31, 2024
FIRST TRUST EXCHANGE-TRADED FUND VI	0.00%	2,565	-	-	Mar 31, 2024
KP Funds	0.00%	19,500	-	-	Sep 30, 2020
CARILLON SERIES TRUST	0.00%	23,863	-	-	Mar 31, 2024
VANGUARD VARIABLE INSURANCE FUNDS	0.00%	20,245	-	-	Mar 31, 2024
Adviser Managed Trust	0.00%	620	-	-	Jan 31, 2024
ALLSPRING MASTER TRUST	0.00%	23,880	-	-	Feb 29, 2024
Meeder Funds	0.00%	1,655	-	-	Mar 31, 2024
GPS Funds I	0.00%	1,666	-	-	Mar 31, 2024
EMPOWER FUNDS, INC.	0.00%	342,000	-	-	Mar 31, 2024
PROFESSIONALLY MANAGED PORTFOLIOS	0.00%	20,000	-	-	Feb 29, 2024
GraniteShares ETF Trust	0.00%	534	33	6.59%	Sep 30, 2021
Advisors' Inner Circle Fund III	0.00%	28,220	-	-	Jan 31, 2024
NUVEEN INVESTMENT FUNDS INC	0.00%	7,208	-	-	Jan 31, 2024
ETF Series Solutions	0.00%	4,588	-	-	Jan 31, 2024
NEW COVENANT FUNDS	0.00%	905	-	-	Dec 31, 2023
EMPOWER FUNDS, INC.	0.00%	234,000	-	-	Mar 31, 2024
THRIVENT MUTUAL FUNDS	0.00%	17,635	-	-	Mar 28, 2024
Forethought Variable Insurance Trust	0.00%	704	-	-	Mar 28, 2024
CLEARWATER INVESTMENT TRUST	0.00%	1,400	-	-	Mar 28, 2024
Invesco Exchange-Traded Self-Indexed Fund Trust	0.00%	32,162	-	-	Feb 29, 2024
Chartwell Funds	0.00%	2,794	-	-	Jun 30, 2022
THRIVENT SERIES FUND INC	0.00%	13,375	-	-	Mar 28, 2024
Invesco Exchange-Traded Fund Trust II	0.00%	37,063	-43,153	-53.80%	Feb 29, 2024
INVESCO EXCHANGE-TRADED FUND TRUST	0.00%	7,885	6	0.08%	Jan 31, 2024
Global X Funds	0.00%	3,925	-168	-4.10%	Feb 29, 2024
PUTNAM FUNDS TRUST	0.00%	18,333	-	-	Jan 31, 2024
iSHARES TRUST	0.00%	1,104,650	-7,258	-0.65%	Mar 31, 2024
MORGAN STANLEY PATHWAY FUNDS	0.00%	6,647	-	-	Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS	0.00%	125,257	10,601	9.25%	Feb 29, 2024
COLLEGE RETIREMENT EQUITIES FUND	0.00%	65,318	-69,906	-51.70%	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	12,932	-47,092	-78.46%	Jan 31, 2024
JANUS INVESTMENT FUND	0.00%	14,482	-	-	Dec 31, 2023
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST	0.00%	2,552	-	-	Dec 31, 2023

NovoCure's largest mutual fund holder by % of total assets is "SPARROW FUNDS", owning 5.80K shares, compromising 1.63% of its total assets.

NovoCure Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	244	-5.43%
31 Mar, 24	258	7.05%
31 Dec, 23	241	-5.12%
30 Sep, 23	254	-12.41%
30 Jun, 23	290	-9.09%
31 Mar, 23	319	-5.62%
31 Dec, 22	338	6.29%
30 Sep, 22	318	-3.64%
30 Jun, 22	330	2.17%
31 Mar, 22	323	-3.58%
31 Dec, 21	335	-2.33%
30 Sep, 21	343	-11.60%
30 Jun, 21	388	11.17%
31 Mar, 21	349	-9.59%
31 Dec, 20	386	25.32%
30 Sep, 20	308	5.48%
30 Jun, 20	292	-2.34%
31 Mar, 20	299	6.03%
31 Dec, 19	282	5.62%
30 Sep, 19	267	23.61%
30 Jun, 19	216	1.89%
31 Mar, 19	212	21.84%
31 Dec, 18	174	-8.42%
30 Sep, 18	190	8.57%
30 Jun, 18	175	25.00%
31 Mar, 18	140	3.70%
31 Dec, 17	135	19.47%
30 Sep, 17	113	22.83%
30 Jun, 17	92	21.05%
31 Mar, 17	76	-8.43%
31 Dec, 16	83	20.29%
30 Sep, 16	69	-8.00%
30 Jun, 16	75	11.94%
31 Mar, 16	67	31.37%
31 Dec, 15	51	-

As of 30 Jun 24, 244 institutions are holding NovoCure's shares, representing a decrease of -5.43% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	92,913,118	4.09%
31 Mar, 24	89,258,298	-1.39%
31 Dec, 23	90,513,161	-0.77%
30 Sep, 23	91,218,726	0.53%
30 Jun, 23	90,741,465	1.46%
31 Mar, 23	89,436,759	5.80%
31 Dec, 22	84,530,682	1.55%
30 Sep, 22	83,242,221	3.28%
30 Jun, 22	80,595,848	-1.01%
31 Mar, 22	81,414,379	3.14%
31 Dec, 21	78,936,827	1.91%
30 Sep, 21	77,454,960	-0.20%
30 Jun, 21	77,610,402	3.18%
31 Mar, 21	75,220,652	1.43%
31 Dec, 20	74,160,322	1.30%
30 Sep, 20	73,207,678	5.93%
30 Jun, 20	69,108,663	-1.82%
31 Mar, 20	70,391,820	1.48%
31 Dec, 19	69,361,804	3.96%
30 Sep, 19	66,716,734	1.28%
30 Jun, 19	65,875,605	3.69%
31 Mar, 19	63,532,368	10.77%
31 Dec, 18	57,357,245	4.84%
30 Sep, 18	54,707,156	5.61%
30 Jun, 18	51,803,367	17.71%
31 Mar, 18	44,008,501	17.53%
31 Dec, 17	37,444,923	1.71%
30 Sep, 17	36,813,608	15.45%
30 Jun, 17	31,886,103	57.68%
31 Mar, 17	20,222,622	-0.30%
31 Dec, 16	20,282,543	7.74%
30 Sep, 16	18,826,214	-3.16%
30 Jun, 16	19,440,644	42.77%
31 Mar, 16	13,616,823	20.75%
31 Dec, 15	11,276,605	-

NovoCure (NVCR) has 92.91M shares outstanding as of 30 Jun 24, up 4.09% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	86.62%	1.23%
31 Mar, 24	83.90%	1.17%
31 Dec, 23	84.77%	1.15%
30 Sep, 23	85.82%	1.16%
30 Jun, 23	85.87%	1.20%
31 Mar, 23	84.64%	1.31%
31 Dec, 22	80.48%	1.28%
30 Sep, 22	79.37%	1.34%
30 Jun, 22	77.03%	1.26%
31 Mar, 22	78.14%	1.34%
31 Dec, 21	76.32%	1.37%
30 Sep, 21	74.67%	1.33%
30 Jun, 21	75.00%	1.40%
31 Mar, 21	73.29%	1.38%
31 Dec, 20	72.75%	1.39%
30 Sep, 20	72.32%	1.54%
30 Jun, 20	68.62%	1.38%
31 Mar, 20	70.48%	1.39%
31 Dec, 19	71.33%	1.55%
30 Sep, 19	67.74%	1.45%
30 Jun, 19	68.37%	1.52%
31 Mar, 19	67.01%	1.72%
31 Dec, 18	62.46%	1.80%
30 Sep, 18	58.88%	1.83%
30 Jun, 18	56.72%	2.37%
31 Mar, 18	48.91%	2.73%
31 Dec, 17	42.29%	2.48%
30 Sep, 17	41.31%	3.16%
30 Jun, 17	36.14%	6.76%
31 Mar, 17	23.12%	4.23%
31 Dec, 16	23.38%	4.85%
30 Sep, 16	21.95%	4.22%
30 Jun, 16	22.80%	8.76%
31 Mar, 16	16.13%	9.04%
31 Dec, 15	13.36%	-

As of 30 Jun 24, NovoCure is held by 86.62% institutional shareholders, representing a 1.23% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	121	-3.20%
31 Mar, 24	125	-2.34%
31 Dec, 23	128	5.79%
30 Sep, 23	121	9.01%
30 Jun, 23	111	-17.16%
31 Mar, 23	134	-12.99%
31 Dec, 22	154	17.56%
30 Sep, 22	131	-7.09%
30 Jun, 22	141	-2.76%
31 Mar, 22	145	-15.70%
31 Dec, 21	172	17.81%
30 Sep, 21	146	-27.36%
30 Jun, 21	201	48.89%
31 Mar, 21	135	-40.27%
31 Dec, 20	226	56.94%
30 Sep, 20	144	-
30 Jun, 20	144	-4.00%
31 Mar, 20	150	10.29%
31 Dec, 19	136	-5.56%
30 Sep, 19	144	27.43%
30 Jun, 19	113	-1.74%
31 Mar, 19	115	35.29%
31 Dec, 18	85	-16.67%
30 Sep, 18	102	-10.53%
30 Jun, 18	114	78.13%
31 Mar, 18	64	-14.67%
31 Dec, 17	75	7.14%
30 Sep, 17	70	12.90%
30 Jun, 17	62	129.63%
31 Mar, 17	27	-47.06%
31 Dec, 16	51	41.67%
30 Sep, 16	36	-25.00%
30 Jun, 16	48	23.08%
31 Mar, 16	39	-17.02%
31 Dec, 15	47	-

121 institutional shareholders have increased their position in NVCR stock as of 30 Jun 24 compared to 125 in the previous quarter (a -3.20% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	67	6.35%
31 Mar, 24	63	12.50%
31 Dec, 23	56	-11.11%
30 Sep, 23	63	-33.68%
30 Jun, 23	95	-1.04%
31 Mar, 23	96	6.67%
31 Dec, 22	90	-12.62%
30 Sep, 22	103	-6.36%
30 Jun, 22	110	-
31 Mar, 22	110	20.88%
31 Dec, 21	91	-19.47%
30 Sep, 21	113	-0.88%
30 Jun, 21	114	-15.56%
31 Mar, 21	135	50.00%
31 Dec, 20	90	-6.25%
30 Sep, 20	96	24.68%
30 Jun, 20	77	-6.10%
31 Mar, 20	82	-2.38%
31 Dec, 19	84	2.44%
30 Sep, 19	82	34.43%
30 Jun, 19	61	-4.69%
31 Mar, 19	64	-
31 Dec, 18	64	12.28%
30 Sep, 18	57	62.86%
30 Jun, 18	35	-28.57%
31 Mar, 18	49	53.13%
31 Dec, 17	32	39.13%
30 Sep, 17	23	64.29%
30 Jun, 17	14	-44.00%
31 Mar, 17	25	108.33%
31 Dec, 16	12	-14.29%
30 Sep, 16	14	16.67%
30 Jun, 16	12	-20.00%
31 Mar, 16	15	-
31 Dec, 15	-	-

67 institutional shareholders have reduced their position in NVCR stock as of 30 Jun 24 compared to 63 in the previous quarter (a 6.35% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	244	-5.43%	92,913,118	4.09%	86.62%	1.23%	121	-3.20%	67	6.35%
31 Mar, 24	258	7.05%	89,258,298	-1.39%	83.90%	1.17%	125	-2.34%	63	12.50%
31 Dec, 23	241	-5.12%	90,513,161	-0.77%	84.77%	1.15%	128	5.79%	56	-11.11%
30 Sep, 23	254	-12.41%	91,218,726	0.53%	85.82%	1.16%	121	9.01%	63	-33.68%
30 Jun, 23	290	-9.09%	90,741,465	1.46%	85.87%	1.20%	111	-17.16%	95	-1.04%
31 Mar, 23	319	-5.62%	89,436,759	5.80%	84.64%	1.31%	134	-12.99%	96	6.67%
31 Dec, 22	338	6.29%	84,530,682	1.55%	80.48%	1.28%	154	17.56%	90	-12.62%
30 Sep, 22	318	-3.64%	83,242,221	3.28%	79.37%	1.34%	131	-7.09%	103	-6.36%
30 Jun, 22	330	2.17%	80,595,848	-1.01%	77.03%	1.26%	141	-2.76%	110	-
31 Mar, 22	323	-3.58%	81,414,379	3.14%	78.14%	1.34%	145	-15.70%	110	20.88%
31 Dec, 21	335	-2.33%	78,936,827	1.91%	76.32%	1.37%	172	17.81%	91	-19.47%
30 Sep, 21	343	-11.60%	77,454,960	-0.20%	74.67%	1.33%	146	-27.36%	113	-0.88%
30 Jun, 21	388	11.17%	77,610,402	3.18%	75.00%	1.40%	201	48.89%	114	-15.56%
31 Mar, 21	349	-9.59%	75,220,652	1.43%	73.29%	1.38%	135	-40.27%	135	50.00%
31 Dec, 20	386	25.32%	74,160,322	1.30%	72.75%	1.39%	226	56.94%	90	-6.25%
30 Sep, 20	308	5.48%	73,207,678	5.93%	72.32%	1.54%	144	-	96	24.68%
30 Jun, 20	292	-2.34%	69,108,663	-1.82%	68.62%	1.38%	144	-4.00%	77	-6.10%
31 Mar, 20	299	6.03%	70,391,820	1.48%	70.48%	1.39%	150	10.29%	82	-2.38%
31 Dec, 19	282	5.62%	69,361,804	3.96%	71.33%	1.55%	136	-5.56%	84	2.44%
30 Sep, 19	267	23.61%	66,716,734	1.28%	67.74%	1.45%	144	27.43%	82	34.43%
30 Jun, 19	216	1.89%	65,875,605	3.69%	68.37%	1.52%	113	-1.74%	61	-4.69%
31 Mar, 19	212	21.84%	63,532,368	10.77%	67.01%	1.72%	115	35.29%	64	-
31 Dec, 18	174	-8.42%	57,357,245	4.84%	62.46%	1.80%	85	-16.67%	64	12.28%
30 Sep, 18	190	8.57%	54,707,156	5.61%	58.88%	1.83%	102	-10.53%	57	62.86%
30 Jun, 18	175	25.00%	51,803,367	17.71%	56.72%	2.37%	114	78.13%	35	-28.57%
31 Mar, 18	140	3.70%	44,008,501	17.53%	48.91%	2.73%	64	-14.67%	49	53.13%
31 Dec, 17	135	19.47%	37,444,923	1.71%	42.29%	2.48%	75	7.14%	32	39.13%
30 Sep, 17	113	22.83%	36,813,608	15.45%	41.31%	3.16%	70	12.90%	23	64.29%
30 Jun, 17	92	21.05%	31,886,103	57.68%	36.14%	6.76%	62	129.63%	14	-44.00%
31 Mar, 17	76	-8.43%	20,222,622	-0.30%	23.12%	4.23%	27	-47.06%	25	108.33%
31 Dec, 16	83	20.29%	20,282,543	7.74%	23.38%	4.85%	51	41.67%	12	-14.29%
30 Sep, 16	69	-8.00%	18,826,214	-3.16%	21.95%	4.22%	36	-25.00%	14	16.67%
30 Jun, 16	75	11.94%	19,440,644	42.77%	22.80%	8.76%	48	23.08%	12	-20.00%
31 Mar, 16	67	31.37%	13,616,823	20.75%	16.13%	9.04%	39	-17.02%	15	-
31 Dec, 15	51	-	11,276,605	-	13.36%	-	47	-	-	-

NovoCure Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Aug 05, 2024	Cordova Ashley	officer	Chief Financial Officer	S-Sale	Sell	688	$20.14	$13.86K	219,179
Jun 06, 2024	VERNON W ANTHONY	director	-	S-Sale	Sell	964	$23.89	$23.03K	164,833

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 05, 2024	Cordova Ashley	officer	Chief Financial Officer	S-Sale	Sell	688	$20.14	$13.86K	219,179
Jun 07, 2024	GROENHUYSEN WILHELMUS CM	officer	Chief Operating Officer	M-Exempt	Sell	124,373	$7.15	$889.27K	95,000
Jun 06, 2024	VERNON W ANTHONY	director	-	S-Sale	Sell	964	$23.89	$23.03K	164,833

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 06, 2024	Ben Arye Barak	officer	General Counsel	A-Award	Buy	930	$12.24	$11.38K	118,052
Aug 06, 2024	GROENHUYSEN WILHELMUS CM	officer	Chief Operating Officer	A-Award	Buy	1,055	$12.24	$12.91K	252,290
Aug 06, 2024	Danziger Asaf	director, officer	Chief Executive Officer	A-Award	Buy	1,239	$12.24	$15.17K	15,228
Aug 06, 2024	Cordova Ashley	officer	Chief Financial Officer	A-Award	Buy	1,286	$12.24	$15.74K	220,465
Aug 06, 2024	Leonard Frank X	officer	EVP, Pres., Novocure Oncology	A-Award	Buy	1,736	$12.24	$21.25K	161,834
Aug 06, 2024	Puri Michal Nath	officer	Chief Human Resources Officer	A-Award	Buy	1,736	$12.24	$21.25K	110,903
Aug 05, 2024	Cordova Ashley	officer	Chief Financial Officer	S-Sale	Sell	688	$20.14	$13.86K	219,179
Jun 07, 2024	GROENHUYSEN WILHELMUS CM	officer	Chief Operating Officer	M-Exempt	Buy	124,373	$22.82	$2.84M	124,373
Jun 07, 2024	GROENHUYSEN WILHELMUS CM	officer	Chief Operating Officer	M-Exempt	Sell	124,373	$7.15	$889.27K	95,000
Jun 06, 2024	Ocean Allyson J	director	-	A-Award	Buy	6,229	$23.13	$144.08K	6,229
Jun 06, 2024	Ocean Allyson J	director	-	A-Award	Buy	4,053	-	-	4,053
Jun 06, 2024	Madden Martin J.	director	-	A-Award	Buy	4,053	-	-	19,673
Jun 06, 2024	Madden Martin J.	director	-	A-Award	Buy	6,229	$23.13	$144.08K	6,229
Jun 06, 2024	Hung David	director	-	A-Award	Buy	4,053	-	-	13,194
Jun 06, 2024	Hung David	director	-	A-Award	Buy	6,229	$23.13	$144.08K	6,229
Jun 06, 2024	Stafford Kristin	director	-	A-Award	Buy	6,229	$23.13	$144.08K	6,229
Jun 06, 2024	Stafford Kristin	director	-	A-Award	Buy	4,053	-	-	4,053
Jun 06, 2024	VERNON W ANTHONY	director	-	A-Award	Buy	4,053	-	-	169,850
Jun 06, 2024	VERNON W ANTHONY	director	-	S-Sale	Sell	964	$23.89	$23.03K	164,833
Jun 06, 2024	VERNON W ANTHONY	director	-	A-Award	Buy	6,229	$23.13	$144.08K	6,229

The last insider sell of NovoCure's stock was made by Cordova Ashley on Aug 05 2024, selling 688 shares at $20.14 per share (valued at $13.86K).

NovoCure Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2024	-	2	-
Q3 2024	-	2	-
Q2 2024	23	5	460.00%
Q1 2024	16	24	66.67%
Q4 2023	8	5	160.00%
Q3 2023	-	14	-
Q2 2023	18	-	-
Q1 2023	35	48	72.92%
Q4 2022	3	3	100.00%
Q3 2022	11	18	61.11%
Q2 2022	12	20	60.00%
Q1 2022	25	24	104.17%
Q4 2021	3	1	300.00%
Q3 2021	19	49	38.78%
Q2 2021	22	49	44.90%
Q1 2021	30	62	48.39%
Q4 2020	6	33	18.18%
Q3 2020	43	139	30.94%
Q2 2020	22	32	68.75%
Q1 2020	34	36	94.44%

0 total buy trades, and 2 total sell trades (buy/sell ratio of 0.00%) were made by NovoCure's insiders, as of Q4 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2024	-	-	-
Q3 2024	-	1	-
Q2 2024	-	3	-
Q1 2024	-	6	-
Q4 2023	-	1	-
Q3 2023	-	4	-
Q2 2023	-	-	-
Q1 2023	-	43	-
Q4 2022	-	2	-
Q3 2022	-	17	-
Q2 2022	-	3	-
Q1 2022	-	20	-
Q4 2021	3	1	300.00%
Q3 2021	-	21	-
Q2 2021	-	38	-
Q1 2021	-	48	-
Q4 2020	-	26	-
Q3 2020	1	80	1.25%
Q2 2020	-	13	-
Q1 2020	-	22	-

As of Q4 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of NovoCure's stocks.

NovoCure Peer Ownership

Ticker	Company
TMDX	TransMedics Group, Inc.
MASI	Masimo Corporation
ITGR	Integer Holdings Corporation
INMD	InMode Ltd.
PODD	Insulet Corporation
LIVN	LivaNova PLC
IRTC	iRhythm Technologies, Inc.
PEN	Penumbra, Inc.
GMED	Globus Medical, Inc.
NARI	Inari Medical, Inc.
INSP	Inspire Medical Systems, Inc.
SWAV	ShockWave Medical, Inc.
CNMD	CONMED Corporation

NVCR Ownership FAQ

Who Owns NovoCure?

NovoCure is owned by institutional shareholders (86.62%), insiders (9.22%), and public (4.16%). The largest institutional shareholder of NovoCure is FMR LLC (15.05% of total shares) and the top mutual fund owner is SPARROW FUNDS (1.63% of total shares).

Who are the major institutional shareholders of NovoCure?

NovoCure's major institutional shareholders are FMR LLC, BLACKROCK INC., CAPITAL INTERNATIONAL INVESTORS, VANGUARD GROUP INC, and STATE STREET CORP. The top five shareholders own together 50.44% of the company's share outstanding.

How many NovoCure shareholders are there?

As of Jun 2024, there are 244 institutional shareholders of NovoCure.

What percentage of NovoCure is owned by FMR LLC?

FMR LLC owns 16.14M shares of NovoCure, representing 15.05% of the company's total shares outstanding, valued at $276.51M (as of Jun 2024).

What percentage of NovoCure is owned by BLACKROCK INC?

As of Jun 2024, BLACKROCK INC holds 12.13M shares of NovoCure (NVCR), compromising 11.31% of the company, valued at $207.83M.

What percentage of NovoCure is owned by CAPITAL INTERNATIONAL INVESTORS?

CAPITAL INTERNATIONAL INVESTORS is the third largest holder of NovoCure. The company owns 11.7M of the company's shares outstanding (worth $200.36M).